← Back to Search

Plasma Device

Plasma Treatment for Acne/Rosacea

N/A
Recruiting
Research Sponsored by The Skin Center Dermatology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnoses of target conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial found that a device that emits plasma can help improve skin conditions.

Who is the study for?
This trial is for individuals with certain skin conditions like Molluscum Contagiosum, Bowen's Disease, warts, and various forms of keratosis and acne. Participants must be able to follow the study procedures. Specific exclusions depend on the individual's condition.
What is being tested?
The study is testing a device that uses cold atmospheric plasma to treat different skin disorders including lesions and acne. It also looks at using this technology indirectly to help with hair loss associated with these skin conditions.
What are the potential side effects?
Potential side effects may include temporary redness, irritation or discomfort at the treatment site. Since it's non-thermal plasma, heat-related injuries are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with the specific condition required.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinical improvement

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Non-thermal atmospheric plasma treatmentExperimental Treatment1 Intervention
Device treatment
Group II: Indirect non-thermal atmospheric plasma treatmentExperimental Treatment1 Intervention
A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound

Find a Location

Who is running the clinical trial?

The Skin Center Dermatology GroupLead Sponsor
3 Previous Clinical Trials
67 Total Patients Enrolled

Media Library

Indirect non-thermal, atmospheric plasma (Plasma Device) Clinical Trial Eligibility Overview. Trial Name: NCT02759900 — N/A
Actinic Keratosis Research Study Groups: Non-thermal atmospheric plasma treatment, Indirect non-thermal atmospheric plasma treatment
Actinic Keratosis Clinical Trial 2023: Indirect non-thermal, atmospheric plasma Highlights & Side Effects. Trial Name: NCT02759900 — N/A
Indirect non-thermal, atmospheric plasma (Plasma Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02759900 — N/A
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top